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structures of the stilbenolignans were deﬁned using spectral analysis and their mechanisms of formation
are discussed. Anti-oxidant and anti-inﬂammatory activities of the novel stilbenolignans were tested, and
the lactone stilbenolignan was observed to exhibit potent anti-oxidant activity.
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Biomimetic synthesis of active stilbenolignan derivatives by oxidative coupling and acid-catalyzed polymerization 1031. Introduction
Stilbenolignans are a type of natural compound formed from
stilbene and phenylpropanoid. So far only a few stilbeno-
lignans have been found as natural products, indicating
their narrow distribution and limited production in plants1–6.
There is little information in the literature with regard
to the biological activities and biomimetic synthesis of
stilbenolignans7–9.
In previous studies from our research group, ﬁve natural
stilbenolignans, gnetucleistol F, gnetofuran A, lehmbachol D,
gnetifolin F, and gnetumontanin C were isolated from Gnetum
cleistostachyum. Four of these compounds were synthesized by
an oxidative coupling reaction, and they were found to exhibit
potent anti-inﬂammatory activities in pharmacological test-
ing9. With our continued investigation into the biomimetic
synthesis of stilbenolignans, two new stilbenolignan deriva-
tives 1 and 2 were synthesized through an oxidative coupling
reaction with ferulic acid (3), sinapinic acid (4) and iso-
rhapontigenin (5) as the starting materials. Further, a novel
lactone stilbenolignan derivative 6 and a known tetralin
derivative 9 were synthesized by acid-catalyzed polymerization
of ferulic acid and isorhapontigenin (Fig. 1)10. Tests for anti-
oxidative and anti-inﬂammatory activities showed that com-
pound 6 could exhibit potent anti-oxidant activity with an
IC50 value of 5.27 106 M. Here, we report the synthesis,
structural elucidation, possible mechanisms of formation and
activities of these novel stilbenolignans.Figure 1 Synthetic routes for2. Results and discussion
An esteriﬁcation reaction of ferulic acid in methanol saturated
with hydrochloric acid was carried out at room temperature to
obtain methyl ferulate (7) in 96% yield. Then, an oxidative
coupling reaction of methyl ferulate and isorhapontigenin in
acetone, with Ag2O as oxidant, was carried out to generate
stilbenolignan 1. Similarly, sinapinic acid was converted into
its methyl ester 8 in methanol saturated with hydrochloric
acid, which then resulted in the production of stilbenolignan 2
through an oxidative coupling reaction with isorhapontigenin
in acetone, with Ag2O as the oxidant. A solution of ferulic
acid and isorhapontigenin in concentrated hydrochloric acid
was stirred for 72 h at room temperature to obtain stilbeno-
lignan 6 and tetralin derivative 910. Of the two, stilbenoligan 6
was found to be a novel derivative of gnetumontanin C. The
structures of products 1, 2 and 6 were established as
described below.
Compound 1 was a light grayish amorphous powder. On
FAB-MS analysis, the compound showed a molecular ion
peak at m/z 464 [M]þ, and together with the 1H NMR and
13C NMR spectra (Table 1), indicated a molecular formula of
C26H24O8, indicating that stilbenolignan 1 could be a dimer of
an isorhapontigenin and a methyl ferulate. The ultraviolet
spectrum of 1 showed absorption bands at lmax 205 and
325 nm, indicating the presence of a strong conjugated system
in 1; on IR spectroscopy, the compound exhibited evidence
of hydroxyls (nmax 3400 cm
1), an ester carbonyl groupcompounds 1, 2, 6, and 9.
Table 1 1H and 13C NMR data of compounds 1 and 2 (d
in ppm and J in Hz)n.
Position
1 2
1H 13C 1H 13C
1a 140.7 140.7
2a 7.20 brs 116.5 7.20 brs 116.4
3a 145.5 145.6
4a 148.7 148.8
5a 129.1 129.2
6a 7.15 brs 112.1 7.15 brs 112.1
7a 7.04 d, 16.5 127.8 7.09 d, 16.8 127.8
8a 6.98 d, 16.5 127.1 6.98 d, 16.8 127.1
9a 132.3 131.2
10a 6.54 d, 1.8 105.7 6.55 d, 1.8 105.7
11a 159.6 159.6
12a 6.27 brs 102.8 6.28 brs 102.8
13a 159.6 159.6
14a 6.54 d, 1.8 105.7 6.55 d, 1.8 105.7
1b 132.6 132.6
2b 7.08 d, 1.5 110.6 6.78 s 104.8
3b 147.8 148.8
4b 148.5 137.1
5b 6.81 d, 8.1 115.8 148.8
6b
6.89 dd, 8.1,
1.5
120.1 6.78 s 104.8
7b 5.97d, 7.8 87.9 5.98 d, 8.1 88.1
8b 4.42 d, 7.8 52.9 4.45 d, 8.1 52.9
9b 171.9 171.9
OCH3
3.94 s 56.3 3.79 (s, OCH3) 56.6
3.83 s 56.4 3.80 (s, 2OCH3) 56.4
3.79 s 56.2 3.90 (s, OCH3) 56.3
nMeasured in (CD3)2CO at 300 MHz for
1H NMR and
75 MHz for 13C NMR.
Chunsuo Yao et al.104(nmax 1734 cm
1), and aromatic rings (nmax 1604, 1518 and
1464 cm1). The 1H NMR spectrum displayed two coupled
aliphatic protons at d 4.42 (1H, d, J¼7.8 Hz) and 5.97 (1H, d,
J¼7.8 Hz) due to the dihydrobenzofuran ring; there was one
set of proton signals of the ABX system at d 6.81(1H, d,
J¼8.1 Hz), 6.89 (1H, dd, J¼8.1, 1.5 Hz), and 7.08 (1H, d,
J¼1.5 Hz) for ring A; and another set of proton signals of the
AB2 system at d 6.27 (1H, brs) and 6.54 (2H, d, J¼1.8 Hz) for
ring D; in addition, there were two coupled trans-oleﬁnic
protons at d 6.98 (1 H, d, J¼16.5 Hz) and 7.04 (1 H, d,
J¼16.5 Hz) as well as two meta-coupled aromatic signals at d
7.15 (1H, brs) and 7.20 (1H, brs) for ring C and three singlet
signals for three methoxyls. The 13C NMR spectrum of
stilbenolignan 1 demonstrated 24 signals that represented 26
carbons. These data indicated that 1 had a similar skeletal
structure to that of gnetofuran A, isolated from Gnetum
cleistostachyum9. The difference between the two was that a
hydroxymethyl group at C-8a in gnetofuran A was substituted
by a methoxycarbonyl in compound 1. In the NOE difference
experiments (Fig. 2), the enhancements of H-2b, H-6b, and H-
6a on irradiation of H-8b, and the enhancements of H-2b and
H-6b on irradiation of H-7b conﬁrmed the trans-relative
conﬁguration of H-7b and H-8b. Accordingly, the structure
of 1 was constructed, and it appeared to be a new derivative of
the natural stilbenolignan gnetofuran A.Compound 2 was obtained as an off-white amorphous
powder. The EI-MS m/z 494 [M]þ, in combination with the
1H NMR and 13C NMR spectra (Table 1), helped generate a
molecular formula of C27H26O9 for the compound, which then
indicated that it could be a dimer of an isorhapontigenin and a
methyl sinapate. The UV spectrum of the compound indicated
the presence of a strong conjugated system at lmax 206 and
325 nm; the IR spectrum showed the occurrence of an
hydroxyl (nmax 3402 cm
1), an ester carbonyl (nmax
1736 cm1) and an aromatic ring (nmax 1608, 1520 and
1464 cm1). The 1H NMR spectrum of 2 displayed resonances
of a set of AB2 system at d 6.28 (1H, brs) and 6.55 (2H, d,
J¼1.8 Hz); an aromatic singlet represented two protons at d
6.78 (2H, s), two meta-coupled aromatic protons at d 7.15 (1H,
brs), and 7.20 (1H, brs), two aliphatic protons at d 4.45 (1H, d,
J¼8.1 Hz) and 5.98 (1H, d, J¼8.1 Hz), two trans-coupled
oleﬁnic protons at d 6.98 (1H, d, J¼16.8 Hz) and 7.09 (1H, d,
J¼16.8 Hz), and four methoxyl protons at d 3.79 (3H, s), 3.80
(6H, s), and 3.90 (3H, s). The 13C NMR spectrum of 2
exhibited 21 signals that represented 27 carbons. These data
indicate that 2 could be a stilbenolignan with a dihydroben-
zofuran ring, which resembles the skeletal structure of gnetu-
cleistol F9. Reﬁned analysis of the NMR spectral data of the
two compounds revealed that the major difference between
them was the replacement of a hydroxymethyl group in
gnetucleistol F by a methoxycarbonyl in 2. In the NOE
difference experiments (Fig. 2), irradiation of H-7b resulted
in enhancement of H-2b (6b), and irradiation of H-8b resulted
in enhancement of H-2b (6b) and H-6a, indicating the trans-
relative conﬁguration of H-7b and H-8b. Therefore, the
structure of 2 was determined.
Compound 6 was an off-white solid. An FAB-MS m/z 434
[M]þ, in combination with 1H NMR and 13C NMR data
(Table 2), provided a molecular formula of C25H22O7, indicat-
ing that 6 could be a dimer of an isorhapontigenin and a
ferulic acid. The UV spectrum showed absorption bands at
lmax 207 and 283 nm, indicating the presence of a strong
conjugated system in 6. The IR spectrum showed the existence
of hydroxyl group (nmax 3344 cm
1), ester carbonyl (nmax
1749 cm1), double bond (nmax 1631 cm
1), and an aromatic
ring (nmax 1591, 1514 and 1466 cm
1). The 1 H NMR spectrum
of 6 exhibited signals for a set of ABX system at d 6.70 (1H, d,
J¼7.8 Hz), 6.77 (1H, d, J¼7.8 Hz), and 6.96 (1H, s); signals
for a set of meta-coupled aromatic protons at d 7.15 (1H, d,
J¼1.8 Hz) and 6.44 (1H, d, J¼1.8 Hz), two singlets of
aromatic protons at d 6.39 (1H, s) and 6.74 (1H, s), six
aliphatic protons at d 3.01 (1H, d, J¼6.6 Hz), 3.61 (1 H, t,
J¼13.5 Hz), 4.12 (1 H, dd, J¼6.6, 13.5 Hz), 3.24 (1 H, dd,
J¼7.5, 16.2 Hz), 3.46 (1H, d, J¼16.2 Hz), and 5.13 (1H, d,
J¼7.5 Hz). Two methoxyl protons at d 3.77 (3H, s) and 3.80
(3H, s) were observed. The 13C NMR spectrum of 6 showed 25
carbon signals (a carbonyl carbon, 18 aromatic carbons, 4
aliphatic carbons, and 2 methoxyl carbons). These data
indicated that 6 possessed a structure similar to gnetumonta-
nin C, which is a stilbene derivative containing a lactonic
ring6. Compound 6 has two aliphatic carbon signals and three
aliphatic proton signals more than gnetumontanin C, and has
two less oleﬁnic carbon signals than the stilbene derivative;
therefore, the structure of 6 was noted to have one ring more
than in gnetumontanin C. This was conﬁrmed by a reﬁned
analysis of the HMBC spectrum (Fig. 3). In the HMBC
spectrum, the correlations between H-7a and C-1a, C-2a,
Figure 2 NOE interactions of stilbenolignans 1 and 2.
Table 2 1H and 13C NMR data of compound 6n.
Position
6 Position 6
1H 13C HMBC 1H 13C HMBC
1a 133.8 12a 6.30 brs 102.0 10a, 13a, 14a, 9b
2a 6.96 s 112.4 4a, 6a, 7a 13a 158.1
3a 146.1 14a 6.64 d, 1.8 112.5 8a, 10a
4a 145.8 1b 130.8
5a 6.70 d, 7.8 115.9 1a 2b 6.74 s 107.7 4b, 6b, 7b
6a 6.77 d, 7.8 121.4 3b 148.3
7a 4.12 dd,6.6,13.5 50.9 1a,2a,6a,8a, 1b,6b 4b 145.9
8ab 3.01 d, 6.6 41.7 1a,7a,9a,10a,14a 5b 6.39 s 121.2 1b, 4b, 7b
8ab 3.61 t, 13.5 7a,9a,10a, 14a, 6b 6b 141.2
9a 140.6 7b 5.13 d, 7.5 34.2 9a,10a,11a,1b,2b,6b, 8b, 9b
10a 118.6 8ba 3.24 dd,7.5,16.2
32.8
1b, 7b, 9b
11a 151.1 8bb 3.46 d,16.2 1b, 7b, 9b, 10a
CH3 3.80 s 56.3 9b 168.7
CH3 3.77 s 56.1
nMeasured in (CD3)2CO at 300 MHz for
1H NMR and 75 MHz for 13C NMR.
Figure 3 The HMBC (a) and NOE (b) interactions of 6.
Biomimetic synthesis of active stilbenolignan derivatives by oxidative coupling and acid-catalyzed polymerization 105C-6a, C-8a, C-1b, and C-6b; H-8aa and C-7a, C-9a, C-10a, C-
14a, and C-6b; H-8ab and C-1a, C-7a, C-9a, C-10a, and C-
14a, and H-5b and C-1b, C-4b, and C-7a indicated that the
connection between C-7a and C-6b resulted in the formation
of a seven-membered ring in the structure of 6, which was
further conﬁrmed by the crosses of H-7b and C-1b, C-2b, C-
6b, C-8b, C-9b, C-9a, C-10a, and C-11a. In addition, the
relative conﬁguration of 6 was discussed. In NOE experiments
(Fig. 3), the enhancements of H-8aa and H-8ba on irradiation
of H-7b implied the cis conﬁguration of H-7b, H-8aa, and H-
8ba. The enhancements of H-8ba and H-2b on irradiation of
H-8bb indicated a trans conﬁguration of H-8bb and H-7b. The
enhancements of H-8ab, H-2a, and H-5b on irradiation of H-7a, and the enhancements of H-8ab and H-7b on irradiation of
H-8aa indicated a cis conﬁguration of H-7a and H-8ab.
Therefore, the structure of 6 was elucidated as shown in
Fig. 1, and was considered a new derivative of the naturally
occurring gnetumontanin C.
On the basis of the oxidative coupling reaction of iso-
rhapontigenin7–9, the possible mechanisms of formation of
stilbenolignans 1 and 2 were interpreted as described below:
with Ag2O as the oxidant, isorhapontigenin produced the free
radicals R4  , R5  , and R8  , and methyl ferulate (or methyl
sinapate) produced Re04  and Re08  (or Re004  and Re008  ,
Fig. 4), respectively. Thus, coupling of free radicals of R5 
and Re08  (or Re008  ) generates unstable intermediates 10a (or
10b), which produced 1 (as well as 2, Fig. 5) through
intramolecular cyclization. In addition, the possible mechan-
isms of acid-catalyzed polymerization of compounds 3 and 5
may be hypothesized as follows: the esteriﬁcation of 3 and 5
produced an intermadiate 11.
An acidic protonation of the oleﬁnic bond on the ferulic
acid moiety was followed by cyclization to produce inter-
mediate 12, which formed 6 after undergoing a second
cyclization (Fig. 6). In the course of the reaction, two
cyclization reactions may be carried out in coordination
because no product lacking a seven-membered ring was
observed.
The pharmacological activities of anti-oxidation and anti-
inﬂammation have been evaluated. As shown in Table 3, none
Figure 4 Possible free radicals in the oxidative coupling reaction.
Figure 5 Postulated intermediates in the formation of 1 and 2.
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Figure 6 Possible formation routes of 6 in HCl.
Table 3 TNFa and MDA inhibitory activities of 6 and
9n.
Compd TNFa inhibitory rates
(%)]
MDA inhibitory
activities
1 8.62 –
2 7.83 –
6 11.33 5.27 106 M (IC50)
9 9.83 24.483 (IR)]
nDexamethasone was used as a positive control for TNFa
with IC50 value of 1 106 M, and Vit E was used for MDA
with IC50 value of 1 106 M.
]Concentration: 1 105 M.
Chunsuo Yao et al.106was found to be active on TNFa (dexamethasone was used as
a positive control for TNFa with IC50 value of 1 106 M).As the inhibitory rate of malondialdehyde (MDA) formation
for compound 9 at a concentration of 1 105 M was
24.48%, and the IC50 value of MDA for 6 was
5.27 106 M (Vitamine E was used as a positive control
for MDA with IC50 value of 1 106 M), indicating that the 6
could exhibit potent anti-oxidant activity.3. Experimental
3.1. General experimental procedures
Melting points of compounds were determined with a
GERMANY-68992 apparatus. Optical rotations were deter-
mined on a Perkin–Elmer digital polarimeter. The IR spectra
were run on a Perkin–Elmer 683 infrared spectrometer in KBr
pellets. The UV spectrum was obtained on a Shimadzu UV-
300 spectrophotometer. NMR spectra were carried out on
AM 500 using TMS as internal standard. High-performance
Biomimetic synthesis of active stilbenolignan derivatives by oxidative coupling and acid-catalyzed polymerization 107liquid chromatography was carried out on a Waters 411
equipped with a 2487 detector and a 510 pump. The EI-MS
and HR-FAB-MS were obtained on a QB-200 mass
spectrometer.
3.2. Synthesis of compounds 7 and 8
Compound 3 (8 g, 41.24 mmol) was dissolved in methanol
saturated with hydrochloric acid. The solution was kept
standing for 48 h at room temperature, with occasional
stirring. The solution was concentrated to obtain 7 (8.2 g),
with a yield of 96%. Similarly, compound 4 was treated using
the same method to afford 8 (1.0 g), with a yield of 96%.
3.3. Synthesis of stilbenolignans 1 and 2
1.5 g Ag2O was added to the solution of methyl ferulate 7
(15 mg) and isorhapontigenin 5 (20 mg) in 10 mL acetone. The
solution was stirred for 8 h at room temperature. The mixture
was ﬁltered and the ﬁltrate was concentrated in vacuo. The
residue obtained was subjected to silica gel column chromato-
graphy to generate stilbenolignan 1 (5 mg). In addition,
methyl sinapate 8 (15 mg) and isorhapontigenin 5 (20 mg)
were treated using the same method to obtain stilbenolignan 2
(6 mg).
3.4. Synthesis of stilbenolignan 6 and tetralin derivative 9
A solution of 1 g ferulic acid 3 and 1 g isorhapontigenin 5 in
40 mL concentrated hydrochloric acid was stirred for 72 h at
room temperature. The mixture was concentrated in vacuo and
50 mL of water was added. The suspension was extracted with
EtOAc (3 50 mL); the combined organic layer was concen-
trated and subjected to silica gel column chromatography with
CHCl3–MeOH (20:1–5:1, v/v) as the eluent to afford fractions
1 and 2. Fraction 1 was further puriﬁed on silica gel column
chromatography with petrol ether–acetone (2:1, v/v) to get
stilbenolignan 6 (50 mg). Fraction 2 was dissolved in methanol
saturated with hydrochloric acid and the solution was kept
standing for 2 days at room temperature, after which the
mixture was concentrated and subjected to silica gel column
chromatography with a cyclohexane–acetone (2:1, v/v) eluent
to obtain the tetralin derivative 9 (500 mg).
Compound 1: a light grayish amorphous powder. [a]20.D ¼0
(c¼0.136, MeOH); FAB-MS m/z 464 [M]þ. HR-FAB-MS: m/
z 464.1492 (464.1471 Calcd for C26H24O8). UV (MeOH) lmax
205, 325 nm; IR (KBr) nmax: 3400, 2952, 2924, 2854, 1734,
1604, 1518, 1464, 1377, 1271, 1142, 1092, 960, 845, 814 cm1.
For 1H NMR and 13C NMR data see Table 1.
Compound 2: an off-white amorphous powder. [a]20.D ¼0
(c¼0.129, MeOH); EI-MS m/z 494 [M]þ. HR-EI-MS: m/z
494.1597 (494.1577 Calcd for C27H26O9). UV (MeOH) lmax
206, 325 nm; IR (KBr) nmax: 3402, 2927, 2850, 1736, 1608,
1520, 1464, 1352, 1213, 1113, 1011, 967, 841, 685 cm1. For
1H NMR and 13C NMR data see Table 1.
Compound 6: a white solid, mp. 182–184 1C; [a]20.D ¼ 0
(c¼0.146, MeOH); FAB-MS m/z 434 [M]þ. HR-FAB-MS:
m/z 434.1389 (434.1366 Calcd for C25H22O7). UV (MeOH)
lmax 207, 283 nm; IR (KBr) nmax: 3344, 2939, 2841, 1749, 1631,
1591, 1514, 1466, 1352, 1284, 1140, 1124, 1028, 814 cm1. For
1H NMR and 13C NMR data see Table 2.Compound 9: a colorless needles (acetone); mp. 131–134 1C;
[a]20.D ¼0 (c¼0.108, MeOH); 1H NMR (300 MHz, in
CD3COCD3): 7.47 (1H, s, OH), 7.42 (1H, s, OH), 6.85 (1H,
s, H-2a), 6.78 (1H, d, J¼1.8 Hz, H-2b), 6.76 (1H, d, J¼7.8 Hz,
H-5b), 6.65 (1H, dd, J¼7.8, 1.8 Hz, H-6b), 6.31 (1H, s, H-5a),
4.58 (1H, d, J¼9.6 Hz, H-7b), 3.90 (1H, dd, J¼7.8, 15.6 Hz,
H-8a), 3.44 (1H, dd, J¼7.8, 9.6 Hz, H-8b), 2.60 (1H, dd,
J¼7.8, 15.6 Hz, H-7aa), 2.43 (1H, dd, J¼7.8, 15.6 Hz, H-7ab),
3.81 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.59 (3H, s, OCH3),
3.64 (3H, s, OCH3).
13C NMR (300 MHz, in CD3COCD3):
173.4 (C¼O), 172.9 (C¼O), 148.3 (C-3b), 147.9 (C-3a), 147.4
(C-4a), 146.4 (C-4b), 137.8 (C-1b), 135.4 (C-1a), 134.9 (C-6a),
121.7 (C-6b), 115.7 (C-5b), 112.5 (C-2a), 112.0 (C-5a), 108.0
(C-2b), 58.8 (C-7b), 56.3 (OCH3), 56.2 (OCH3), 52.2 (C-7a),
51.8 (OCH3), 51.7 (OCH3), 43.1 (C-8b), 37.3 (C-8a).
3.5. Anti-inﬂammatory bioassay
Effects of the compounds on TNFa activity were analyzed in
the supernatant of cultured mouse peritoneal macrophages
stimulated with lipopolysaccharide (LPS). Mouse peritoneal
macrophage (2 109 cells/mL) protein incubated with various
concentrations of compounds was stimulated by LPS (10 mg/
mL) for 12 h. TNFa bioactivity in the supernatant was
quantiﬁed by measuring the absorbance at 570 nm after
staining L929 with crystalviolet11.
3.6. Anti-oxidant bioassay.
The anti-oxidative ability of these compounds was determined
by the content of MDA, a compound that was produced
during microsomal lipid peroxidation induced by ferrous–
cysteine. MDA was detected by using the thiobarbituricacid
(TBA) method. Brieﬂy, 1 mg/mL microsomal protein, differ-
ent concentrations of compound or vehicle, and 0.2 mM
cysteine in 0.1 M PBS were incubated for 15 min at 37 1C,
after which 0.5 mM ferrous sulfate was added and incubated
for 15 min at 37 1C again. An equal volume of 20% TCA was
added to terminate the reaction and centrifuged for 10 min at
3000 rpm. The supernatant fractions were mixed with 0.67%
TBA for 10 min at 100 1C. After cooling, the MDA was
quantiﬁed by determining the absorbance at 532 nm and then
the inhibition rate was calculated12.
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